BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 5378459)

  • 1. [Value of cyto-hormonal smears in the conduct of androgenic treatment of women with breast cancer].
    Marsan C; Sicard A
    Presse Med (1893); 1969 Dec; 77(54):2033-6. PubMed ID: 5378459
    [No Abstract]   [Full Text] [Related]  

  • 2. [The importance of cyto-hormonal smears in the conduct of androgenic treatment in women with cancer of the breast].
    Marsan C; Sicard A
    Minerva Ginecol; 1971 May; 23(9):420-8. PubMed ID: 5099353
    [No Abstract]   [Full Text] [Related]  

  • 3. Vaginal cytology during hormonal treatment of breast cancer.
    Grattarola M
    J Radiol Electrol Med Nucl; 1967 Nov; 48(11):800-1. PubMed ID: 5591687
    [No Abstract]   [Full Text] [Related]  

  • 4. Androgens in breast cancer. III. Breast cancer recurrences years after mastectomy and increased androgenic activity.
    Grattarola R; Secreto G; Recchione C
    Am J Obstet Gynecol; 1975 Jan; 121(2):169-72. PubMed ID: 1115123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hormonal prevention of recurrence and metastasis in the complex treatment of breast cancer].
    Vishniakova EG
    Vopr Onkol; 1968; 14(3):74-9. PubMed ID: 4968229
    [No Abstract]   [Full Text] [Related]  

  • 6. [Results of hormonal treatment of breast cancer with special reference to preventive therapy].
    Schmidt H; Bauer R
    Strahlentherapie; 1968 Sep; 136(3):259-62. PubMed ID: 5685748
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hormonal cytology used in the therapy of breast cancer (author's transl)].
    Filaun J; Kubát A; Leitnerová S
    Arch Geschwulstforsch; 1977; 47(7):649-51. PubMed ID: 606200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maturation of vaginal and endometrial epithelium in postmenopausal breast cancer patients receiving long-term tamoxifen.
    Lahti E; Vuopala S; Kauppila A; Blanco G; Ruokonen A; Laatikainen T
    Gynecol Oncol; 1994 Dec; 55(3 Pt 1):410-4. PubMed ID: 7835781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrovaginal potentials, vaginal cytology, and hormone therapy.
    Dederick MM; Hall TC; Yatsuhashi JW; Nevinny HB
    Surg Gynecol Obstet; 1966 Oct; 123(4):751-4. PubMed ID: 5920369
    [No Abstract]   [Full Text] [Related]  

  • 10. [Behavior of hormonal patterns in breast neoplasms. Physiopathologic and clinical considerations].
    Giordano G; Cacciari P
    Arch Sci Med (Torino); 1968 Oct; 125(10):525-35. PubMed ID: 5735716
    [No Abstract]   [Full Text] [Related]  

  • 11. The management of advanced breast cancer.
    Hunt PS; Nemoto T
    Med J Aust; 1970 Sep; 2(13):591-4. PubMed ID: 5471114
    [No Abstract]   [Full Text] [Related]  

  • 12. DHEA and its transformation into androgens and estrogens in peripheral target tissues: intracrinology.
    Labrie F; Luu-The V; Labrie C; Simard J
    Front Neuroendocrinol; 2001 Jul; 22(3):185-212. PubMed ID: 11456468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vaginal trophism after treatment with estriol and HCG. Comparative histomorphological and biochemico-hormonal study].
    Scaglione V; Casati G
    Minerva Ginecol; 1981 Dec; 33(12):1141-50. PubMed ID: 7335240
    [No Abstract]   [Full Text] [Related]  

  • 14. The study of the excretion of estrogens in patients with breast cancer treated with androgens.
    Sharoukhova KS; Muraviova NI; Kurockin IF; Vishnyakova VV
    Neoplasma; 1972; 19(4):331-4. PubMed ID: 5054533
    [No Abstract]   [Full Text] [Related]  

  • 15. The importance of sex chromatin determination in the hormonal treatment of breast cancer.
    Siracká E; Simko I; Siracký J
    Neoplasma; 1970; 17(6):625-9. PubMed ID: 5505379
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of pulmonary metastases of the breast cancer using sex hormones].
    Kubović M; Jakasa D
    Plucne Bolesti Tuberk; 1974; 26 Suppl 2():372-4. PubMed ID: 4445362
    [No Abstract]   [Full Text] [Related]  

  • 17. [Utilization of high-dose norethindrone in the treatment of some genital hormono-dependent cancers].
    Sonkin R; Coudeyras M; Thévenet M
    Gynecol Obstet (Paris); 1969; 68(4):355-72. PubMed ID: 5354375
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hormonal treatment with non-virilizing androgens, in a case of extensive bone metastasis of an epithelioma of the breast].
    Tardiveau J; Philippon J
    J Radiol Electrol Med Nucl; 1970 Dec; 51(12):801-2. PubMed ID: 5510215
    [No Abstract]   [Full Text] [Related]  

  • 19. Sex chromatin and hormonal treatment in breast cancer with bone metastases.
    Siracká E; Siracký J
    Neoplasma; 1969; 16(2):205-8. PubMed ID: 5822920
    [No Abstract]   [Full Text] [Related]  

  • 20. Is vulvovaginal atrophy due to a lack of both estrogens and androgens?
    Labrie F; Martel C; Pelletier G
    Menopause; 2017 Apr; 24(4):452-461. PubMed ID: 27875388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.